AIZ
Assurant, Inc.
AIZ's fundamentals are mixed: earnings per share grew 29%, while its operating margin rose 1 points to 9.8%. At 15x earnings, it's trading right at its usual valuation. Analysts expect earnings growth.
BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
AIZ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
AIZ's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AIZ.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AIZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $254 | -21% |
| Forward | 13x | $321 | — |
| Fair | 15x | $328 | +2.1% |
| Current | 15x | $321 | — |
| Expensive | 22x | $469 | +46% |
Historical ranges are pointers, not guarantees.
AIZ's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over AIZ in the historical PE scenario, which offers more potential upside but is not a forecast.
AIZ Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for AIZ, with profitability improving.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
AIZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $23.95 | +13% |
| Q3 2026 | $21.22 | +29% |
| Q2 2026 | $20.90 | +51% |
| Q1 2026 | $19.51 | +52% |
| Q4 2025 | $16.93 | +17% |
| Q3 2025 | $16.42 | +17% |
| Q2 2025 | $13.80 | -7.9% |
| Q1 2025 | $12.82 | -10% |
| Q4 2024 | $14.46 | +21% |
AIZ earned $21.22 per share over the past year, up 29% from the year before.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over AIZ on earnings, with more consistent year-over-year improvement.
AIZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.5B | +9.2% |
| Q2 2026 | $3.5B | +9.4% |
| Q1 2026 | $3.4B | +11% |
| Q4 2025 | $3.4B | +7.9% |
| Q3 2025 | $3.2B | +8.9% |
| Q2 2025 | $3.2B | +8% |
| Q1 2025 | $3.1B | +6.7% |
| Q4 2024 | $3.1B | +4.1% |
AIZ's revenue has grown year over year for 16 quarters in a row: $3.5B last quarter, up 9.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.9% | -0.3 points |
| Q2 2026 | 11% | +1.8 points |
| Q1 2026 | 9.8% | +3.8 points |
| Q4 2025 | 8.5% | +0.4 points |
| Q3 2025 | 10% | +5.2 points |
| Q2 2025 | 9.2% | +1.2 points |
| Q1 2025 | 6% | -4.2 points |
| Q4 2024 | 8.1% | +0.5 points |
AIZ's operating margin was 9.9% last quarter, about level with the same quarter a year ago.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over AIZ on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over AIZ on profitability, with a higher operating margin.
AIZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $620.3M | +40% |
| Q2 2026 | $409.2M | +99% |
| Q1 2026 | $192.6M | -43% |
| Q4 2025 | $611.7M | +1658% |
| Q3 2025 | $442.1M | +14% |
| Q2 2025 | $205.6M | -69% |
| Q1 2025 | $339M | +969% |
| Q4 2024 | $34.8M | -89% |
AIZ has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
AIZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -115K shares |
| 1 year | -3.1% | -1.6M shares |
| 3 years | -7.5% | -4M shares |
| 5 years | -16% | -9.8M shares |
| Available history | -20% | -12.6M shares |
AIZ has 50M diluted shares, down 3.1% from a year ago, with $372M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $75.7M |
| Q2 2026 | $77.6M |
| Q1 2026 | $124.2M |
| Q4 2025 | $94.3M |
| Q3 2025 | $81.8M |
| Q2 2025 | $63.3M |
| Q1 2025 | $64.3M |
| Q4 2024 | $120.3M |
AIZ spent $372M buying back its own shares over the past year, up 13% from the year before.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over AIZ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AIZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.3x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.2x | Very low |
AIZ has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
AIZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 77.0 | Overbought |
| Stochastic | 83.0 | Overbought |
AIZ's weekly RSI is 77 (overbought) and its Stochastic is 83 (overbought).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AIZ PE vs Financial Services Sector
| Metric | AIZ | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 16% above |
| PE % | 45 | 63 | 18 pts below |
AIZ is trading at 15x earnings, a 16% premium to the Financial Services sector's median of 13x.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over AIZ on valuation relative to its sector.
AIZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $286.0 | 12% above |
| 20 week MA | $283.6 | 13% above |
| 50 week MA | $254.7 | 26% above |
| 100 week MA | $230.3 | 39% above |
| 200 week MA | $195.3 | 64% above |
AIZ has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
AIZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $129.7 | $132.6 | +2.3% |
| 2021 | $132.6 | $152.3 | +15% |
| 2022 | $152.3 | $125.0 | -18% |
| 2023 | $125.0 | $168.5 | +35% |
| 2024 | $168.5 | $215.1 | +28% |
| 2025 | $215.1 | $240.1 | +12% |
| 2026 YTD | $240.1 | $321.1 | +34% |
AIZ has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.